NeoGenomics said last week it finalized an agreement to acquire GE Healthcare‘s (NYSE:GE) cancer diagnostic subsidiary Clarient for up to $275 million. GE Healthcare originally purchased Clarient for nearly double that price at approximately $587 million in 2011. NeoGenomics said the acquisition would allow it to broaden its cancer diagnostic testing offerings to both hospitals and physicians […]
Mergers & Acquisitions
PositiveID picks up Thermomedics
PositiveID (OTC:PSID) said yesterday it acquired non-contact thermometer manufacturer Thermomedics for $750,000 up front and another possible $750,000 in 2016 and 2017 dependent upon reaching certain milestones. Thermomedics produces the Caregiver non-contact clinical-grade infrared thermometer, which is FDA cleared for measuring forehead temperature in adults, children and infants. No skin contact is required to use the […]
Bovie snatches up Bulgarian R&D and manufacturing contractor
Bovie Medical (NYSE:BVX) said yesterday it bought its Bulgarian R&D and manufacturing contractor for $570,000 (EU€500,000). The deal was made for cash over a 5-year period, with an initial payment of $427,000 (EU€375,000) made at closing, and a remaining payment of $143,000 (EU€125,000) due in October, 2020, the Clearwater, Fla.-based company said. “We are pleased to […]
AmSurg makes $5.3B bid to combine with TeamHealth
(Reuters) — AmSurg proposed a $5.3 billion merger with TeamHealth Holdings Inc as it looks to add heft to its business that provides doctors to hospitals and other healthcare services. AmSurg, which revealed on today that private merger talks with TeamHealth fell through in September, said it had gone public with the offer to persuade TeamHealth […]
Valeant closes $166m Synergetics buyout
Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) last week said it closed the $166 million acquisition of ophthalmic and neurosurgical device maker Synergetics. Valeant’s $6.50-per-share offer was a 48.1% premium over Synergetics stock’s closing price the day before the deal was announced last month. The buyout includes $1 per share in milestones, with a 50¢-per-share bonus tied to an annual sales […]
Allergan closes $300m AqueSys buyout
Allergan (NYSE: AGN) said today that it closed its $300 million, all-cash acquisition of AqueSys and its Xen soft glaucoma stent, in a deal that also includes unspecified milestone payments. The device made by Aliso Viejo, Calif.-based AqueSys is designed to treat glaucoma by shunting intra-ocular fluid from the anterior chamber of the eye into the sub-conjunctival […]
Digirad picks up DMS Health for $36m
Digirad Corp. (NSDQ:DRAD) said earlier this week it picked up DMS Health for $36 million. Fargo, N.D.-based DMS Health provides mobile diagnostic imaging and related sales and other services to regional hospitals, concentrated in the midwest, Digirad said. “We believe this acquisition represents a significant milestone in Digirad’s history, and should generate considerable value for our […]
Johnson & Johnson CFO Caruso: $10B share buyback doesn’t affect M&A appetite
The $10 billion share repurchasing program revealed yesterday by Johnson & Johnson (NYSE:JNJ) won’t affect the healthcare giant’s appetite for mergers & acquisitions, especially when it comes to bolstering the cardiovascular portfolio of its struggling medical device division, CFO Dominic Caruso said this week. For J&J, which announced the buyback Oct. 13 along with its 3rd-quarter numbers, […]
Smith & Nephew CEO Bohuon: M&A chatter is disruptive
The perennial chatter over the potential acquisition of Smith & Nephew (FTSE:SN, NYSE:SNN) is disruptive and unwelcome, CEO Olivier Bohuon said this week. “It has disrupted our sales force because every day they are with [competitors] who are saying, ‘By the way, we are going to buy you,’” Bohuon told the Financial Times. Bohuon has long […]
AtriCure closes $99m nContact buy
AtriCure (NSDQ:ATRC) said yesterday that it closed the $99 million cash-and-stock buyout of cardiac ablation device maker nContact. Morrisville, N.C.-based nContact makes a system that’s designed to combine vacuum suction, perfusion and radiofrequency ablation to improve contact between cardiac tissue and the device. The company is running a U.S. investigational device exemption trial, comparing its Convergent procedure using the […]
IBM closes $1B Merge Healthcare buyout
International Business Machine (NYSE:IBM) said it finished its $1 billion purchase of medical image and clinical systems company Merge Healthcare. Merge shareholders are slated to receive $7.13 per share in cash as the transaction closes, the Armonk, N.Y.-based company said. IBM said it will combine the newly purchased assets, including data and images from Merge Healthcare’s medical imaging […]